Dr. Daniel R. Lewis

Board Certification:Oncology & HematologyFellowship Training:Oncology & Hematology from University California DavisInternal Medicine Residency:Cornell UniversityMedical School:Institute of Medicine I, Ragoon, BurmaEducation:Masters of Public Health and Tropical Medicine Tulane UniversityAreas of Interest: Benign Hematology, Breast Cancer, Gastrointestinal Malignancies, Lung Cancer, Solid Tumors. Dr. Soe is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Kevin Kim, MD, grew up in the Seattle, Washington area. He obtained his undergraduate education at the University of Chicago and attended Tufts University in Boston, Massachusetts, for his medical degree. He received training in Internal Medicine residency and Hematology/Oncology fellowship at Scripps Clinic/Green Hospital in La Jolla, California.After completing his training in 2010, he joined Kootenai Clinic Cancer Services in Coeur d’Alene, Idaho. He was instrumental in achieving the Cancer Center’s prestigious National Accreditation Program for Breast Centers (NAPBC). As well, he is a strong proponent of clinical trials to improve patient care.Dr. Kim strives to balance his experience and knowledge of individualized cancer care with a deep empathy and compassion for his patients. He believes in building a partnership with his patients. Additionally, he supports patient education that optimizes patients’ understanding of their disease and treatment options.He comes to the Central Coast with his beautiful wife, Anna Kim, MD, and two amazing children. He enjoys many outdoor activities, such as surfing, fishing, golfing, skiing and hiking. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Hemochromatosis. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome.

Dr. Wei Bai grew up in Beijing, China. In 1995, she graduated from Peking University Health Science Center (previously known as Beijing Medical University) with distinction. She then pursued graduate study in the United States. Upon receiving her master’s degree in Molecular Medicine from the University of Massachusetts Medical School in 1998, Dr. Bai joined a leading biotech company, Genentech, Inc., in South San Francisco to pursue her passion in translational research. She participated in research and development of several cancer drugs, including trastuzumab (Herceptin), bevacizumab (Avastin), and erlotinib (Tarceva), among others in the company pipeline.Excited to bring bench research to bedside practice, Dr. Bai ultimately transitioned to direct patient care in 2005. She completed her Internal Medicine residency at NewYork-Presbyterian Lower Manhattan Hospital in 2008, which included several months of clinical rotation at Memorial loan Kettering Cancer Center (MSKCC). Dr. Bai’s experience at MSKCC further enforced her commitment to oncology research and practice. She proceeded to a combined Hematology and Medical Oncology fellowship at Lombardi Comprehensive Cancer Center of Georgetown University in Washington DC from 2008 to 2011.After her fellowship, Dr. Bai practiced hematology and medical oncology in the Samaritan Health System in Oregon. During her nine years with Samaritan, she treated patients with a wide range of cancer types and blood diseases. She served her patients with PRIDE — passion, respect, integrity, dedication and excellence. Dr. Bai was also active in clinical trials and resident education.Since 2020, Dr. Bai joined the team at Mission Hope Cancer Center. Compassionate and calm, she is devoted to each individual patient’s needs and goals. Dr. Bai is rated as an Advanced provider by MediFind in the treatment of Hemochromatosis. Her top areas of expertise are Deep Vein Thrombosis, Pleuropulmonary Blastoma, Familial Colorectal Cancer, and Hemochromatosis.